Structural Aspects of the Allergen-Antibody Interaction

Frontiers in Immunology

Maksymilian Chruszcz¹  Anna Pomés²  Geoffrey A. Mueller³ 

[1] Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, United States;Indoor Biotechnologies, Inc., Charlottesville, VA, United States;National Institute of Environmental Health Sciences, Durham, NC, United States;

关键词: allergy;    allergen;    IgE antibody;    structure;    X-ray crystallography;    nuclear magnetic resonance;   

DOI  :  10.3389/fimmu.2020.02067

来源: DOAJ

【 摘 要 】

The development of allergic disease involves the production of IgE antibodies upon allergen exposure in a process called sensitization. IgE binds to receptors on the surface of mast cells and basophils, and subsequent allergen exposure leads to cross-linking of IgE antibodies and release of cell mediators that cause allergy symptoms. Although this process is quite well-understood, very little is known about the epitopes on the allergen recognized by IgE, despite the importance of the allergen-antibody interaction for the allergic response to occur. This review discusses efforts to analyze allergen-antibody interactions, from the original epitope mapping studies using linear peptides or recombinant allergen fragments, to more sophisticated technologies, such as X-ray crystallography and nuclear magnetic resonance. These state-of-the-art approaches, combined with site-directed mutagenesis, have led to the identification of conformational IgE epitopes. The first structures of an allergen (egg lysozyme) in complex with Fab fragments from IgG antibodies were determined in the 1980s. Since then, IgG has been used as surrogate for IgE, due to the difficulty of obtaining monoclonal IgE antibodies. Technical developments including phage display libraries have contributed to progress in epitope mapping thanks to the isolation of IgE antibody constructs from combinatorial libraries made from peripheral blood mononuclear cells of allergic donors. Most recently, single B cell antibody sequencing and human hybridomas are new breakthrough technologies for finally obtaining human IgE monoclonal antibodies, ideal for epitope mapping. The information on antigenic determinants will facilitate the design of hypoallergens for immunotherapy and the investigation of the fundamental mechanisms of the IgE response.

【 授权许可】

Unknown